[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.128.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1970

Cortisol Production in Depressive IllnessA Clinical and Biochemical Clarification

Author Affiliations

Bronx, NY
From the divisions of psychiatry (Dr. Sachar) and neoplastic medicine (Dr. Hellman), and the Institute for Steroid Research (Drs. Fukushima and Gallagher), Montefiore Hospital and Medical Center, and the departments of psychiatry (Dr. Sachar), medicine (Dr. Hellman), and biochemistry (Drs. Fukushima and Gallagher), Albert Einstein College of Medicine, Bronx, NY.

Arch Gen Psychiatry. 1970;23(4):289-298. doi:10.1001/archpsyc.1970.01750040001001
Abstract

THIS paper will attempt to clarify the relation of clinical features of depressive illness to the secretory activity of the adrenal cortex.

The discovery that psychological stress stimulates the anterior pituitary-adrenocortical system1 has led to considerable interest in studying the function of the adrenal cortex in patients with mental illnesses, including depressions. In a recent review paper,2 Sachar pointed out that the extensive literature describing levels of adrenocortical hormones in depressed patients was quite inconsistent, with many reports suggesting elevated corticosteroid levels and other reports suggesting normal corticosteroid levels, some suggesting good correlation of severity of illness with adrenocortical indices, and others reporting poor correlations. It appeared that neglect of several significant control issues had contributed to the apparent diversity in findings. These necessary controls include eliminating all drugs which may interfere with the release of adrenocorticotropic hormone (ACTH), giving the patient enough time to get over

First Page Preview View Large
First page PDF preview
First page PDF preview
×